*It helps people counter negative thoughts and take control of their moods
*It is recommended by Nice as the first-line treatment for sufferers
*There are not enough cognitive therapists to meet the demand
*Its benefits have been exaggerated and it is less effective than claimed
*We will always need drugs for sufferers from severe depression
Morin, C. M. (2010). Canadian Psychology/Psychologie canadienne, 51(1), 31-39.
Insomnia is a prevalent public health problem that carries an important psychosocial and economic burden for those affected, their families, employers, and for society at large. Despite its negative impacts, insomnia often remains untreated and, when treatment is initiated, it is predominantly with medication, an option that is not always acceptable to people with insomnia. There is extensive evidence that psychological approaches, primarily cognitive behavioural therapy, are effective, produce durable and generalizable outcomes, and should be the first line therapy for chronic insomnia. Nonetheless, these approaches remain under utilised in clinical (medical) practise. Several innovative and cost-effective treatment delivery models (e.g., telephone consultations, Internet-based treatment) have yielded promising results but despite these advances, there remains a problem of supply. A significant challenge for the future will be to disseminate more efficiently validated therapies and practise guidelines and increase their use in clinical practise. Additional training opportunities are also needed for psychologists to develop expertise in a new emerging behavioural sleep medicine subspecialty. (PsycINFO Database Record (c) 2010 APA, all rights reserved)
Wampold, B. E., Minami, T., Baskin, T. W., Tierney, S. C. (2002). Journal of Affective Disorders, 68(2-3), 159-165.
Cognitive therapy (CT) for depression has been found to be efficacious for the treatment of depression. In comparison to other psychotherapies, CT has been shown to be approximately equal to behavior therapies, but sometimes superior to "other therapies.' The latter comparison is problematic given that "other therapies' contain bona fide treatments as well as treatments without therapeutic rationale for depression. A meta-analysis was conducted for studies that compared CT to "other therapies' in an earlier meta-analysis, except that in this meta-analysis "other therapies' were classified as bona fide and non-bona fide. The benefits of CT were found to be approximately equal to the benefits of bona fide non-CT and behavioral treatments, but superior to non-bona fide treatments. The results of this study fail to support the superiority of CT for depression. On the contrary, these results support the conclusion that all bona fide psychological treatments for depression are equally efficacious.